These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
334 related articles for article (PubMed ID: 22108860)
1. Efficient reprogramming of human cord blood CD34+ cells into induced pluripotent stem cells with OCT4 and SOX2 alone. Meng X; Neises A; Su RJ; Payne KJ; Ritter L; Gridley DS; Wang J; Sheng M; Lau KH; Baylink DJ; Zhang XB Mol Ther; 2012 Feb; 20(2):408-16. PubMed ID: 22108860 [TBL] [Abstract][Full Text] [Related]
2. Residual expression of the reprogramming factors prevents differentiation of iPSC generated from human fibroblasts and cord blood CD34+ progenitors. Ramos-Mejía V; Montes R; Bueno C; Ayllón V; Real PJ; Rodríguez R; Menendez P PLoS One; 2012; 7(4):e35824. PubMed ID: 22545141 [TBL] [Abstract][Full Text] [Related]
3. Robust and highly efficient hiPSC generation from patient non-mobilized peripheral blood-derived CD34 Okumura T; Horie Y; Lai CY; Lin HT; Shoda H; Natsumoto B; Fujio K; Kumaki E; Okano T; Ono S; Tanita K; Morio T; Kanegane H; Hasegawa H; Mizoguchi F; Kawahata K; Kohsaka H; Moritake H; Nunoi H; Waki H; Tamaru SI; Sasako T; Yamauchi T; Kadowaki T; Tanaka H; Kitanaka S; Nishimura K; Ohtaka M; Nakanishi M; Otsu M Stem Cell Res Ther; 2019 Jun; 10(1):185. PubMed ID: 31234949 [TBL] [Abstract][Full Text] [Related]
4. Rapid and Efficient Generation of Transgene-Free iPSC from a Small Volume of Cryopreserved Blood. Zhou H; Martinez H; Sun B; Li A; Zimmer M; Katsanis N; Davis EE; Kurtzberg J; Lipnick S; Noggle S; Rao M; Chang S Stem Cell Rev Rep; 2015 Aug; 11(4):652-65. PubMed ID: 25951995 [TBL] [Abstract][Full Text] [Related]
5. Enhanced human somatic cell reprogramming efficiency by fusion of the MYC transactivation domain and OCT4. Wang L; Huang D; Huang C; Yin Y; Vali K; Zhang M; Tang Y Stem Cell Res; 2017 Dec; 25():88-97. PubMed ID: 29125994 [TBL] [Abstract][Full Text] [Related]
6. Efficient Generation of Non-Integration and Feeder-Free Induced Pluripotent Stem Cells from Human Peripheral Blood Cells by Sendai Virus. Ye H; Wang Q Cell Physiol Biochem; 2018; 50(4):1318-1331. PubMed ID: 30355953 [TBL] [Abstract][Full Text] [Related]
7. Enhanced Generation of Integration-free iPSCs from Human Adult Peripheral Blood Mononuclear Cells with an Optimal Combination of Episomal Vectors. Wen W; Zhang JP; Xu J; Su RJ; Neises A; Ji GZ; Yuan W; Cheng T; Zhang XB Stem Cell Reports; 2016 Jun; 6(6):873-884. PubMed ID: 27161365 [TBL] [Abstract][Full Text] [Related]
8. Optimal reprogramming factor stoichiometry increases colony numbers and affects molecular characteristics of murine induced pluripotent stem cells. Tiemann U; Sgodda M; Warlich E; Ballmaier M; Schöler HR; Schambach A; Cantz T Cytometry A; 2011 Jun; 79(6):426-35. PubMed ID: 21548079 [TBL] [Abstract][Full Text] [Related]
9. Generation of human induced pluripotent stem cells from cord blood cells. Nishishita N; Takenaka C; Fusaki N; Kawamata S J Stem Cells; 2011; 6(3):101-8. PubMed ID: 23264996 [TBL] [Abstract][Full Text] [Related]
10. Generation of Human iPSCs by Episomal Reprogramming of Skin Fibroblasts and Peripheral Blood Mononuclear Cells. Febbraro F; Chen M; Denham M Methods Mol Biol; 2021; 2239():135-151. PubMed ID: 33226617 [TBL] [Abstract][Full Text] [Related]
11. Efficient generation of integration-free ips cells from human adult peripheral blood using BCL-XL together with Yamanaka factors. Su RJ; Baylink DJ; Neises A; Kiroyan JB; Meng X; Payne KJ; Tschudy-Seney B; Duan Y; Appleby N; Kearns-Jonker M; Gridley DS; Wang J; Lau KH; Zhang XB PLoS One; 2013; 8(5):e64496. PubMed ID: 23704989 [TBL] [Abstract][Full Text] [Related]
12. A novel model of urinary tract differentiation, tissue regeneration, and disease: reprogramming human prostate and bladder cells into induced pluripotent stem cells. Moad M; Pal D; Hepburn AC; Williamson SC; Wilson L; Lako M; Armstrong L; Hayward SW; Franco OE; Cates JM; Fordham SE; Przyborski S; Carr-Wilkinson J; Robson CN; Heer R Eur Urol; 2013 Nov; 64(5):753-61. PubMed ID: 23582880 [TBL] [Abstract][Full Text] [Related]
13. Direct Reprogramming of Human Primordial Germ Cells into Induced Pluripotent Stem Cells: Efficient Generation of Genetically Engineered Germ Cells. Bazley FA; Liu CF; Yuan X; Hao H; All AH; De Los Angeles A; Zambidis ET; Gearhart JD; Kerr CL Stem Cells Dev; 2015 Nov; 24(22):2634-48. PubMed ID: 26154167 [TBL] [Abstract][Full Text] [Related]
14. Generation of transgene-free human induced pluripotent stem cells with an excisable single polycistronic vector. Papapetrou EP; Sadelain M Nat Protoc; 2011 Aug; 6(9):1251-73. PubMed ID: 21886095 [TBL] [Abstract][Full Text] [Related]
16. iPSCs-based generation of vascular cells: reprogramming approaches and applications. Klein D Cell Mol Life Sci; 2018 Apr; 75(8):1411-1433. PubMed ID: 29243171 [TBL] [Abstract][Full Text] [Related]
17. Zinc finger nuclease-expressing baculoviral vectors mediate targeted genome integration of reprogramming factor genes to facilitate the generation of human induced pluripotent stem cells. Phang RZ; Tay FC; Goh SL; Lau CH; Zhu H; Tan WK; Liang Q; Chen C; Du S; Li Z; Tay JC; Wu C; Zeng J; Fan W; Toh HC; Wang S Stem Cells Transl Med; 2013 Dec; 2(12):935-45. PubMed ID: 24167318 [TBL] [Abstract][Full Text] [Related]
18. Transcriptional Reactivation of OTX2, RX1 and SIX3 during Reprogramming Contributes to the Generation of RPE Cells from Human iPSCs. Li P; Sun X; Ma Z; Liu Y; Jin Y; Ge R; Hao L; Ma Y; Han S; Sun H; Zhang M; Li R; Li T; Shen L Int J Biol Sci; 2016; 12(5):505-17. PubMed ID: 27019633 [TBL] [Abstract][Full Text] [Related]
19. OCT4 and SOX2 Work as Transcriptional Activators in Reprogramming Human Fibroblasts. Narayan S; Bryant G; Shah S; Berrozpe G; Ptashne M Cell Rep; 2017 Aug; 20(7):1585-1596. PubMed ID: 28813671 [TBL] [Abstract][Full Text] [Related]
20. Reprogramming human B cells into induced pluripotent stem cells and its enhancement by C/EBPα. Bueno C; Sardina JL; Di Stefano B; Romero-Moya D; Muñoz-López A; Ariza L; Chillón MC; Balanzategui A; Castaño J; Herreros A; Fraga MF; Fernández A; Granada I; Quintana-Bustamante O; Segovia JC; Nishimura K; Ohtaka M; Nakanishi M; Graf T; Menendez P Leukemia; 2016 Mar; 30(3):674-82. PubMed ID: 26500142 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]